Blood Preparation

Blood Preparation


Global Blood Preparation Market to Reach US$75.4 Billion by 2030

The global market for Blood Preparation estimated at US$50.1 Billion in the year 2023, is expected to reach US$75.4 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. Whole Blood, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$35.2 Billion by the end of the analysis period. Growth in the Blood Derivatives segment is estimated at 6.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.1 Billion While China is Forecast to Grow at 9.3% CAGR

The Blood Preparation market in the U.S. is estimated at US$13.1 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$17.8 Billion by the year 2030 trailing a CAGR of 9.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Blood Preparation Market – Key Trends & Drivers Summarized

How is Blood Preparation Evolving in Modern Medicine?

Blood preparation is an essential aspect of modern medical treatment, involving the collection, processing, and storage of blood and its components for use in various therapeutic applications, including transfusions, surgeries, and treatments for blood disorders. The market for blood preparation is evolving rapidly due to advancements in blood component separation, storage technologies, and the development of blood substitutes. Blood preparation includes the processing of whole blood into components such as red blood cells, platelets, plasma, and clotting factors, which are used to treat a range of conditions, from trauma and surgeries to anemia, cancer, and hemophilia.

Technological innovations in blood preparation have significantly improved the safety, efficacy, and shelf life of blood products. For example, pathogen reduction technologies are being developed to improve the safety of blood transfusions by inactivating viruses, bacteria, and parasites in blood components. Furthermore, advancements in storage solutions and cryopreservation techniques are extending the shelf life of blood products, ensuring that they remain viable for longer periods, which is crucial for emergency situations and remote healthcare settings. These innovations are not only improving the availability of blood products but also reducing the risk of transfusion-related complications.

What Role Does Blood Preparation Play in Treating Blood Disorders?

Blood preparation is critical in the treatment of various blood disorders, including anemia, hemophilia, and leukemia. For patients with anemia, red blood cell transfusions are essential for replenishing the body’s oxygen-carrying capacity, especially in cases of severe blood loss, chronic diseases, or chemotherapy. In patients with clotting disorders such as hemophilia, blood preparation involves the extraction and concentration of clotting factors, particularly Factor VIII and Factor IX, which are essential for preventing and controlling bleeding episodes. These concentrated blood products can be administered to patients to restore normal clotting function, significantly improving their quality of life.

In the case of leukemia and other blood cancers, blood preparation is vital for both supportive care and treatment. Patients undergoing chemotherapy or radiation therapy often require platelet transfusions to prevent bleeding and plasma transfusions to manage clotting abnormalities. Additionally, stem cell transplants, which involve the infusion of healthy blood-forming cells, are an important therapeutic option for patients with certain types of blood cancers. The preparation of blood components for stem cell transplants ensures that patients receive the necessary support during their treatment journey, highlighting the importance of advanced blood processing techniques in modern medical care.

How is Blood Preparation Enhancing Surgical and Emergency Care?

In surgical and emergency care, blood preparation plays a pivotal role in saving lives and improving patient outcomes. During major surgeries, especially those involving significant blood loss, prepared blood components such as red blood cells, plasma, and platelets are often required to maintain the patient’s blood volume, support oxygen delivery, and prevent clotting disorders. The ability to quickly access and transfuse these blood products can make the difference between life and death in critical situations. Additionally, blood preparation is essential in trauma care, where rapid transfusions of blood components are necessary to stabilize patients with severe injuries and hemorrhages.

The development of advanced blood preparation techniques, including preoperative autologous blood donation, where patients donate their own blood before surgery, is enhancing patient safety by reducing the need for allogeneic (donor) blood transfusions. This minimizes the risk of transfusion-related complications such as immune reactions or infections. Furthermore, innovations in portable blood storage and preparation devices are improving the ability of emergency medical teams to provide life-saving transfusions in the field, particularly in remote or disaster-stricken areas. These advancements are enhancing the responsiveness and effectiveness of surgical and emergency care, ensuring that patients receive the critical blood products they need when and where they need them.

What Factors Are Driving the Growth of the Blood Preparation Market?

The growth of the blood preparation market is driven by several factors, including the increasing demand for blood products due to rising surgical procedures, trauma cases, and the growing prevalence of blood disorders. The expanding elderly population, which is more susceptible to chronic diseases and surgeries, is contributing to a higher demand for blood products, particularly red blood cells and platelets. In addition, advancements in blood component separation and storage technologies are improving the availability and safety of blood products, encouraging their use in a wider range of medical applications.

Regulatory support and increasing awareness about the importance of blood donation are also driving the market. Government initiatives aimed at improving blood donation infrastructure and ensuring the safety of the blood supply are contributing to the growth of the blood preparation market. The development of blood substitutes, which are designed to mimic the oxygen-carrying capacity of red blood cells, is another area of innovation that is expected to impact the market. While still in the research phase, these substitutes have the potential to address shortages of donated blood and provide alternatives for patients who are unable to receive traditional blood transfusions. Finally, the rising incidence of trauma cases, surgeries, and the growing prevalence of blood-related conditions are fueling the demand for blood preparation products globally.

Select Competitors (Total 33 Featured) -
  • AstraZeneca plc
  • Baxter International Inc
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Leo Pharma A/S
  • Pfizer, Inc
  • Sanofi
  • Xiamen Hisunny Chemical Co., LTD


Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Blood Preparation – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Demand for Blood and Blood Products in Transfusions Propels Growth in the Blood Preparation Market
Rising Prevalence of Chronic Diseases and Surgeries Expands the Addressable Market for Blood Preparation Products
Technological Advancements in Blood Storage and Preservation Techniques Drive Innovation in Blood Preparation Solutions
Growing Focus on Safe Blood Transfusions Strengthens the Business Case for High-Quality Blood Preparation Methods
Increasing Use of Blood Components in Therapeutic Treatments Expands Market Opportunities for Blood Preparations
Rising Adoption of Apheresis Technology in Blood Collection Drives Demand for Blood Preparation Solutions
Growing Focus on Reducing Transfusion-Transmitted Infections (TTIs) Propels Innovation in Safe Blood Preparation Practices
Increasing Government Initiatives and Blood Donation Programs Fuel Growth in the Blood Preparation Market
Rising Demand for Plasma-Derived Therapies Expands Opportunities for Blood Preparation in Pharmaceutical Applications
Technological Advancements in Blood Separation and Filtration Drive Innovation in Blood Component Preparation
Growing Focus on Reducing Blood Wastage Strengthens Market Demand for Efficient Blood Preparation Techniques
Increasing Use of Blood Preparation in Cancer Treatments and Chemotherapy Expands Market Applications
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Blood Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Blood Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Blood Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Whole Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Whole Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Whole Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Blood Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Blood Derivatives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Blood Derivatives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Blood Derivatives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Renal Impairment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Renal Impairment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Renal Impairment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Thrombocytosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Thrombocytosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Thrombocytosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Pulmonary Embolism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Pulmonary Embolism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Pulmonary Embolism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Angina Blood Vessel Complications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for Angina Blood Vessel Complications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for Angina Blood Vessel Complications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Anticoagulants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 29: World Historic Review for Anticoagulants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 30: World 16-Year Perspective for Anticoagulants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Platelet Aggregation Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 32: World Historic Review for Platelet Aggregation Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 33: World 16-Year Perspective for Platelet Aggregation Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 34: World Recent Past, Current & Future Analysis for Fibrinolytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 35: World Historic Review for Fibrinolytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 36: World 16-Year Perspective for Fibrinolytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 37: World Blood Preparation Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 38: USA Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: USA Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: USA 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
CANADA
TABLE 47: Canada Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Canada 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 53: Canada Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Canada 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
JAPAN
Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 56: Japan Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Japan 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Japan 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 62: Japan Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Japan 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
CHINA
Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 65: China Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: China Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: China 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: China Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: China 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 71: China Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: China Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: China 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
EUROPE
Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 74: Europe Recent Past, Current & Future Analysis for Blood Preparation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Blood Preparation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Blood Preparation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Europe 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Europe 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 83: Europe Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Europe 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
FRANCE
Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 86: France Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: France Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: France 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: France Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: France 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 92: France Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: France Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: France 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
GERMANY
Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 95: Germany Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Germany 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Germany 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 101: Germany Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Germany Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Germany 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
ITALY
TABLE 104: Italy Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Italy 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Italy 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 110: Italy Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Italy Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Italy 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
UNITED KINGDOM
Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 113: UK Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: UK Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: UK 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: UK Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: UK 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 119: UK Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: UK Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: UK 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
SPAIN
TABLE 122: Spain Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Spain Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Spain 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 125: Spain Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Spain Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Spain 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 128: Spain Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Spain Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Spain 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
RUSSIA
TABLE 131: Russia Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Russia Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Russia 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 134: Russia Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Russia Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Russia 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 137: Russia Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Russia Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Russia 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of Europe Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Rest of Europe 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Rest of Europe Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Rest of Europe 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Rest of Europe Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Rest of Europe 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Blood Preparation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 150: Asia-Pacific Historic Review for Blood Preparation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Asia-Pacific 16-Year Perspective for Blood Preparation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Asia-Pacific Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Asia-Pacific 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Asia-Pacific Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Asia-Pacific 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Asia-Pacific Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Asia-Pacific 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
AUSTRALIA
Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 161: Australia Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Australia Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Australia 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 164: Australia Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: Australia Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Australia 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 167: Australia Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: Australia Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: Australia 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
INDIA
Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 170: India Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: India Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: India 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 173: India Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: India Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: India 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 176: India Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: India Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: India 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 179: South Korea Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: South Korea Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: South Korea 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 182: South Korea Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: South Korea Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: South Korea 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 185: South Korea Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: South Korea Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: South Korea 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Rest of Asia-Pacific Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Rest of Asia-Pacific Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: Rest of Asia-Pacific Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
LATIN AMERICA
Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 197: Latin America Recent Past, Current & Future Analysis for Blood Preparation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 198: Latin America Historic Review for Blood Preparation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Latin America 16-Year Perspective for Blood Preparation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 200: Latin America Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Latin America Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Latin America 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 203: Latin America Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Latin America Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Latin America 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 206: Latin America Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: Latin America Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Latin America 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 209: Argentina Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 210: Argentina Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 211: Argentina 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 212: Argentina Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 213: Argentina Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 214: Argentina 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 215: Argentina Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 216: Argentina Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 217: Argentina 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
BRAZIL
TABLE 218: Brazil Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 219: Brazil Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 220: Brazil 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 221: Brazil Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 222: Brazil Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 223: Brazil 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 224: Brazil Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 225: Brazil Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 226: Brazil 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
MEXICO
TABLE 227: Mexico Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 228: Mexico Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 229: Mexico 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 230: Mexico Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 231: Mexico Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 232: Mexico 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 233: Mexico Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 234: Mexico Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 235: Mexico 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 237: Rest of Latin America Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 238: Rest of Latin America 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 240: Rest of Latin America Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 241: Rest of Latin America 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 243: Rest of Latin America Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 244: Rest of Latin America 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
MIDDLE EAST
Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 245: Middle East Recent Past, Current & Future Analysis for Blood Preparation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 246: Middle East Historic Review for Blood Preparation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 247: Middle East 16-Year Perspective for Blood Preparation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 248: Middle East Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 249: Middle East Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 250: Middle East 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 251: Middle East Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 252: Middle East Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 253: Middle East 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 254: Middle East Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 255: Middle East Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 256: Middle East 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
IRAN
TABLE 257: Iran Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 258: Iran Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 259: Iran 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 260: Iran Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 261: Iran Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 262: Iran 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 263: Iran Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 264: Iran Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 265: Iran 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
ISRAEL
TABLE 266: Israel Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 267: Israel Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 268: Israel 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 269: Israel Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 270: Israel Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 271: Israel 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 272: Israel Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 273: Israel Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 274: Israel 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 276: Saudi Arabia Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 277: Saudi Arabia 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 279: Saudi Arabia Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 280: Saudi Arabia 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 282: Saudi Arabia Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 283: Saudi Arabia 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 284: UAE Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 285: UAE Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 286: UAE 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 287: UAE Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 288: UAE Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 289: UAE 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 290: UAE Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 291: UAE Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 292: UAE 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 294: Rest of Middle East Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 295: Rest of Middle East 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 297: Rest of Middle East Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 298: Rest of Middle East 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 300: Rest of Middle East Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 301: Rest of Middle East 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
AFRICA
Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 302: Africa Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 303: Africa Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 304: Africa 16-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2014, 2024 & 2030
TABLE 305: Africa Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 306: Africa Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 307: Africa 16-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2014, 2024 & 2030
TABLE 308: Africa Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 309: Africa Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 310: Africa 16-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings